LOGO TESTATA
Img Testata
Rivista di medicina di laboratorio
Nessuna news trovata
Cerca
Aree Tematiche
ELENCO NUMERI DISPONIBILI
JLM, Vol. 6, N. 1-2, 2005
JLM, Vol. 5, N. 4, 2004
JLM, Vol. 5, N. 3-S1, 2004
JLM, Vol. 5, N. 3, 2004
JLM, Vol. 5, N. 2, 2004
JLM, Vol. 5, N. 1, 2004
JLM, Vol. 4, N. 3-4, 2003
JLM, Vol. 4, N. 2, 2003
JLM, Vol. 4, N. 2-S1, 2003
JLM, Vol. 4, N. 1, 2003
JLM, Vol. 3, N. 4, 2002
JLM, Vol. 3, N. 3, 2002
JLM, Vol. 3, N. 2-S1, 2002
JLM, Vol. 3, N. 1, 2002
JLM, Vol. 2, N. 4, 2001
JLM, Vol. 2, N. 3, 2001
- ematologia
*
- tossicologia
*
- nefrologia
*
- hcv
*
- oncologia
- Serum Chromogranin A and Neuron-Specific Enolase in diagnosis of biologically inactive neuroendocrine tumours
- The controversial issue of malignant histiocytic disorders personal observations and review of the literature
*
- flash
*
- gestione
*
- associazioni
*
- congressi eventi
*
- storia biografia
*
- immunologia
*
JLM, Vol. 2, S. 1, 2001
JLM, Vol. 2, N. 2, 2001
JLM, Vol. 2, N. 1, 2001
JLM, Vol. 1, N. 4, 2000
JLM, Vol. 1, N. 3, 2000
JLM, Vol. 1, S. 1, 2000
JLM, Vol. 1, N. 1-2, 2000
informazioni per gli autori


Editore Sirse Srl
via Corfù, 51 - Brescia
E-mail: info@sirse.com
Sirse srl
www.sirse.net
Rivista Trimestrale -
Iscrizione Tribunale di
Brescia n° 47/2000
ISSN 1592-3479





*

Serum Chromogranin A and Neuron-Specific Enolase in diagnosis of biologically inactive neuroendocrine tumours

L. Giovanella, L. Ceriani, S. La Rosa1, S. Garancini

Laboratory of Endocrinology and Oncology
University Hospital “Ospedale di Circolo e Fondazione Macchi” – Varese (Italy)
1Department of Biological and Clinical Sciences – School of Medicine, University of Insubria – Varese (Italy)

Human Chromogranin-A (CgA) is a 48-kDa protein, encompassing 439 amino acids. It belong to the granine family and it’s largely distributed in secretory granules of endocrine and neuroendocrine cells [1]. CgA is an important marker of neuroendocrine differentiation: its circulating levels are significantly elevated in neuroendocrine tumours (NETs) reflecting the secretory activity of the tumour [2]. CgA assessment in NETs with eutopic secretory activity may be more convenient than urinary detection of 5-hydroxyindolacetic acid (5-HIAA), catecholamines and metabolites [3]. Additionally, CgA measurement may be useful also for the diagnosis and follow up of patients without demonstrated hormonal secretion [4].

Scarica l'articolo
spacer
Pubblicità ed Abbonamenti: Sirse Srl via Corfù, 51 - Tel e Fax 030221522 Brescia E-mail: info@sirse.com
Editore Sirse Srl via Corfù, 51 - Tel e Fax 03021522 Brescia E-mail: info@sirse.com
Rivista Trimestrale - Iscrizione Tribunale di Brescia n° 47/2000 ISSN 1592-3479